The Bill Walsh Translational Cancer Research Laboratory is the research arm of the Medical Oncology Department at Royal North Shore Hospital.
We focus on increasing our understanding of cancer biology and how cancer will behave. We are also working to identify better ways to diagnose cancer.
Through our research we are improving cancer treatment and offering better outcomes for those with the disease.
Cancer
Team Lead
Professor Nick Pavlakis
Co-head, Bill Walsh Translational Cancer Research Laboratory
Associate Professor
Faculty of Medicine and Health
The University of Sydney
Senior Staff Specialist, Dept of Medical Oncology
Royal North Shore Hospital
Professor Stephen Clarke
Co-head, Bill Walsh Translational Cancer Research Laboratory
Professor
Faculty of Medicine and Health
The University of Sydney
Senior Staff Specialist, Dept. Medical Oncology
Royal North Shore Hospital
Associate Professor Helen Wheeler
Associate Professor
Faculty of Medicine and Health
The University of Sydney
Co-team lead, Bill Walsh Translational Cancer Research Laboratory
Senior Staff Specialist
Head Department of Medical Oncology, Royal North Shore Hospital
Co-Lead, Inflammation Flagship
Sydney Vital Translational Cancer Research Centre
Team Members
Dr Emily Colvin
Bill Walsh Translational Cancer Research Laboratory
Lecturer
Faculty of Medicine and Health
The University of Sydney
Associate Professor Connie Diakos
Co-Chair, Cancer
Bill Walsh Translational Cancer Research Laboratory
Conjoint Senior Lecturer
Faculty of Medicine and Health
The University of Sydney
Dr Amanda Hudson
Research Fellow, Bill Walsh Translational Cancer Research Laboratory
Faculty of Medicine and Health
The University of Sydney
Shihani Stoner
Senior Project Officer
Sooin Byeon
Research Assistant
Taymin du Toit-Thompson
PhD Student
Faculty of Medicine and Health
The University of Sydney
Farah Abu Al-Hial
Research Officer
Nada Cheikh-Ali
Clinical Researcher
Hasanthi De Silva
Senior Research Officer
Liz Millar
Research Assistant
Sara Mokhtar
Research Assistant
Narjis Fatima
Postdoctoral Research Associate
Hye Soo Lee
Medical Placement Student
Krishna Kotecha
PhD Student
Faculty of Medicine and Health
The University of Sydney
Joe Wei
Researcher
Dr Alexander Yuile
Bill Walsh Translational Cancer Research Laboratory
Medical Oncologist
Royal North Shore Hospital
- Teaching an Old Drug New Tricks: Can we repurpose an old drug as a new brain cancer treatment?
- The immuno-coagulome: an untapped pathway for new therapeutics in glioma
- Investigating how glioblastoma tumours change over time to become resistant to treatment
- Unravelling the tumour micro-environment to combat brain cancer
- Laying the foundations for improved treatments for IDH-mutated glioma
- The interaction between coagulation, angiogenesis and inflammatory pathways in glioblastoma
- MHF Brain Cancer PACT: Mark Hughes Foundation Collaborative Brain Cancer Pre-clinical pipeline for Advancing Cancer Therapeutics
- Development of non-invasive monitoring for brain tumour recurrence and treatment resistance
- A new class of theranostics for malignant brain cancer
- Radiosensitisation of high-grade gliomas by modulating glucose metabolism
- New Horizons: Therapeutic applications for medicinal cannabis in the treatment of brain cancer
- The role ofIinflammation in colorectal cancer
- Identifying prognostic protein markers in colorectal cancer tumour
- Exploring a new nanotechnology strategy for the neo-adjuvant treatment of colorectal cancer by photodynamic therapy and ionising radiation
- Investigating patterns of drug resistance in ALK rearranged non-small cell lung cancer
- Exploring methods to improve efficacy of immunotherapy in non-small cell lung cancer
- Identification of biomarkers for non-small cell lung cancer
- Chemotherapy resistance in non-small cell lung cancer
- The exhaled breath condensate proteome: a promising source of biomarkers for lung cancer
- Improved treatment for mesothelioma: Can cannabinoids address this unmet need?
- The role of dual PET scans in understanding neuroendocrine tumour behaviour
- Analysing PET scans for neuroendocrine tumours
- Evaluation of lysyl oxidase inhibitors as a new treatment for ovarian cancer
- Investigating the role of long non-coding RNA (ribonucleic acid) in the ovarian cancer microenvironment
- Improving ovarian cancer treatment using nanoparticles
- Biomarker identification for pancreatic cancer diagnosis
- Biomarker identification for pancreatic cancer prognosis.
- Identification of new drug targets for pancreatic cancer treatment
- Understanding the role of tumour microenvironment in pancreatic cancer progression
